Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2023 Results: May 11, 2023

Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish fourth quarter and fiscal year 2023 financial results at 6:00 am ET on Thursday, May 11, 2023. The Company will hold a conference call with investors and analysts to discuss results and…

Read MoreHaemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2023 Results: May 11, 2023

Teladoc Health Launches Provider-Based Care for Weight Management & Prediabetes Programs

 Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, today announced the expansion of Provider-Based Care for weight management and prediabetes programs. Currently available for diabetes and hypertension programs, the addition of Provider-Based Care services for weight management and…

Read MoreTeladoc Health Launches Provider-Based Care for Weight Management & Prediabetes Programs

DaVita, Medtronic raise the curtain on tech company, Mozarc Medical, aiming to bring innovation to kidney care

​DaVita and medical device company Medtronic launched their new venture, Mozarc Medical, to develop new kidney care technologies with a specific focus on at-home treatments. Announced nearly a year ago, the company is co-owned by Medtronic and DaVita, each with equal…

Read MoreDaVita, Medtronic raise the curtain on tech company, Mozarc Medical, aiming to bring innovation to kidney care